Intraday Call [12-08-2021]
Script Name Call No Buy/Sell CMP 1st Target 2nd Target Stop Loss High/Low Remark
Weekly Stock Recommendation [13-09-2021 to 17-09-2021]
Script Name Call No Buy/Sell CMP 1st Target 2nd Target Stop Loss High/Low Remark
RELIANCE W-1 Buy 2425.60 2452 2469++ 2400 - -
AXISBANK W-2 Buy 790 811 817++ 776 - -
ICICIBANK W-3 Buy 720.25 734 739++ 710 - -
ADANIGREEN W-4 Buy 1215.95 1244 1258++ 1188 - -
ANGELBRKG W-5 Buy 1228.85 1254 1267++ 1209 1284 2nd Target Hit
ADANIENT W-6 Buy 1545 1569 1582++ 1515 - Only Risk Trader
Main-line IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Paras Defence and Space Technologies Limited IPO Details 21-09-2021 23-09-2021 ₹ 170.78 Cr ₹ 175 85 ₹ 14,875 -
Sansera Engineering IPO Details 14-09-2021 16-09-2021 ₹ 1282.98 Cr ₹ 744 20 ₹ 14,880 -
Vijaya Diagnostic IPO 01-09-2021 03-09-2021 ₹ 1894.26 Cr ₹ 522 - ₹ 531 28 ₹ 14,868 Available
Ami Organics IPO 01-09-2021 03-09-2021 ₹ 569.64 Cr ₹ 603 - ₹610 24 ₹ 14,640 Available
SME IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Quadpro ITES IPO Details 20-09-2021 22-09-2021 ₹ 14.10 Cr ₹ 20 6000 ₹ 1,20,000 -
SBL Infratech Limited IPO Details 16-09-2021 20-09-2021 ₹ 2.37 Cr ₹ 111 1200 ₹ 1,33,200 -
Markolines Traffic Controls IPO Detail 15-09-2021 20-09-2021 ₹ 40.00 Cr ₹ 78 1600 ₹ 1,24,800 -
Prevest Denpro IPO Details 15-09-2021 17-09-2021 ₹ 26.61 Cr ₹ 84 1600 ₹ 1,34,400 -

Windlas Biotech Limited IPO Details


Founded in the year 2001, Windlas Biotech provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world We employ 954 employees at our four state-of-the-art manufacturing facilities in Dehradun, Uttarakhand India. We also have a salesforce and distribution network spread across 14 states.

We market our own manufactured authentic nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities at affordable prices. “The registered name of the company is Windlas Biotech Limited (Formerly known as Windlas Biotech Private Limited).”
Windlas Biotech Limited IPO Details
Issue Open 04-08-2021
Issue Close 06-08-2021
Allotment Date 11-08-2021
Unblocked Amount 12-08-2021
Credit Demat Amount 13-08-2021
Listing Date 16-08-2021
Issue Size
87,29,130 Total Equity Share
35,87,056 Fresh Issue Equity Share
51,42,067 OFS Equity Share
Issue Size ₹ 401.54 Cr
₹ 165 Cr Fresh
₹ 236.54 Cr OFS
IPO Price Band ₹ 448 - ₹ 460
Minimum Share Bid 30
Minimum Investment Amount [₹]  ₹ 13,800
Face Value ₹ 5
Qualified Institutional Buyer [QIB] 50 %
High Networth Individual [HNI] 15 %
Retail Individual Investor [RII] 35 %
Listing On BSE & NSE
Windlas Biotech Limited IPO Related Link
Windlas Biotech Limited IPO GMP
Windlas Biotech Limited IPO Subscription
Windlas Biotech Limited IPO Allotment Status
Windlas Biotech Limited IPO Grey Market Premium
Date Offer Price Premium Kostak Subject to Sauda Listing Gain Rating
- - - - - - -
- - - - - - -
Windlas Biotech Limited IPO Financial Details (₹ in Cr)
Financial Year Total Asset Total Revenue Total Expenses Profit After Tax
FY-2018 289.887 356.576 336.850 11.198
FY-2019 298.180 311.525 284.188 63.822
FY-2020 3384.88 313.339 299.205 16.213
FY-2021 315.883 430.70 387.17 15.62
Windlas Biotech Limited IPO Valuation Details
Earnings Per Share [EPS] ₹ 7.17
Price/Earnings [P/E] Ratio 64.17
Return on Net Worth [RoNW] 18.19 %
Net Asset Value [NAV] ₹ 109.36 Per Share
Windlas Biotech Limited IPO Subscription Details
As on Date QIB NII RII Total
Shared Offered 17,23,700 13,23,766 30,88,786 61,36,252
Day-1
[04-08-2021]
0
[0]
4,41,990
[0.33]
1,86,52,440
[6.03]
1,90,94,430
[3.111]
Day-2
[05-08-2021]
70,440
[0.04]
14,79,510
[1.11]
4,17,69,420
[13.52]
4,33,19,370
[7.05]
Day-3
[06-08-2021]
4,20,65,880
[24.40]
2,08,26,420
[15.73]
7,44,51,090
[24.10]
13,73,43,390
[22.38]
Windlas Biotech Limited IPO Grey Market Premium
Windlas Biotech Limited IPO Grey Market Premium :- Click Here
Windlas Biotech Limited IPO Allotment Status
Windlas Biotech Limited IPO Allotment Status :- Click Here
 Windlas Biotech Limited IPO Live Subscription
Windlas Biotech Limited IPO Subscription in BSE:- Click Here to View
Windlas Biotech Limited IPO Subscription in NSE:- Click Here to View
Windlas Biotech Limited IPO Prospectus
Windlas Biotech Limited IPO DRHP
Windlas Biotech Limited IPO RHP
Windlas Biotech Limited IPO Contact Details
Windlas Biotech Limited
705-706, Vatika Professional Point
Sector-66, Golf Course Extension Road,
Gurgaon 122 001,
Haryana, India;
Tel: +91 124 2821030
E-mail: grievance@windlasbiotech.com; 
Corporate Identity Number: U74899UR2001PLC033407 
 Windlas Biotech Limited IPO Registrar
Link Intime India Private Limited 
C-101, 1st Floor
247 Park Lal Bhadur Shastri Marg
Vikhroli (West)
Mumbai 400 083
Maharashtra, India
Tel: +91 22 4918 6200
E-mail: windlas.ipo@linkintime.co.in
Investor Grievance ID: 
windlas.ipo@linkintime.co.in
Contact Person: Shanti Gopalkrishnan
SEBI Registration Number: INR000004058
 Windlas Biotech Limited IPO Lead Managers
SBI Capital Markets Limited 
202, Maker Tower ‘E’
Cuffe Parade
Mumbai 400 005
Maharashtra, India
Tel: +91 22 2217 8300
E-mail: windlas.ipo@sbicaps.com 
Investor Grievance ID:
investor.relations@sbicaps.com
Contact Person: Gaurav Mittal/Janardhan Wagle
SEBI Registration Number: MB/INM000003531 

DAM Capital Advisors Limited
One BKC, Tower C, 15th IIFL Securities Limited 
10th Floor, IIFL Centre th Floor, Unit No.1511 
Bandra Kurla Complex, Bandra (East),
Mumbai 400 051
Maharashtra, India
Tel: +91 22 4202 2500
E-mail: windlas.ipo@damcapital.in
Investor Grievance ID: complaint@damcapital.in
Contact Person: Chandresh Sharma
SEBI Registration Number: MB/INM000011336

IIFL Securities Limited 
10th Floor, IIFL Centre 
Kamala City, Senapati Bapat Marg
Lower Parel (West)
Mumbai 400 013
Maharashtra, India
Tel: +91 22 4646 4600
E-mail: windlas.ipo@iiflcap.com
Investor Grievance ID: ig.ib@iiflcap.com
Contact Person: Aditya Agarwal/Harshvardhan Jain
SEBI Registration Number: MB/INM000010940 
Disclaimer:-
       I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
       www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk
        We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO.
       Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.

0 Response to "Windlas Biotech Limited IPO Details"

Post a Comment